Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal de mycologie medicale"
DOI: 10.1016/j.mycmed.2017.11.003
Abstract: BACKGROUND Posaconazole is superior to fluconazole or itraconazole in preventing invasive fungal diseases (IFDs) in patients with haematological malignancies; however, there have been reports of the comparing posaconazole and voriconazole. METHODS This single-centre, retrospective study… read more here.
Keywords: fungal diseases; patients haematological; posaconazole voriconazole; invasive fungal ... See more keywords
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole
Sign Up to like & getrecommendations! Published in 2023 at "Transplant Infectious Disease"
DOI: 10.1111/tid.14045
Abstract: Invasive fungal infections (IFIs) are a common infectious complication during the treatment of acute myeloid leukemia (AML), highârisk myelodysplastic syndrome (MDS) or post hematopoietic cell transplantation (HCT). For these patients, the National Comprehensive Cancer Network… read more here.
Keywords: infections isavuconazole; posaconazole voriconazole; breakthrough fungal; prophylaxis ... See more keywords